Linking Epidermal Barrier Function With Anti-Oxidant Defense

Mechanisms in Skin Conditions

ID Number: NCT03198390

Estimated Study Completion Date  July 1, 2021

Sponsor: University of Arizona

 

Brief Summary:

Investigators will sample the skin and blood of patients with chronic skin conditions (including but not limited to atopic dermatitis (AD), contact dermatitis, hidradenitis suppurativa (HS), and psoriasis) to study the expression of anti-oxidative enzymes, skin barrier proteins and inflammatory molecules. In patients with atopic dermatitis, investigators will also measure skin barrier function using noninvasive devices. These results will be correlated with the disease severity in atopic dermatitis patients.

 

For complete details on this clinical trial see link below:

 

https://clinicaltrials.gov/ct2/show/NCT03198390?cond=Hidradenitis+Suppurativa&cntry=US&draw=5&rank=31

 

Contact: 

University of Arizona - Banner University Medicine Dermatology Tucson, Arizona, United States, 85718

UA Dermatology Clinical Trials Unit 

520-694-1828    uadermatologyresearch@gmail.com   

Principal Investigator: Vivian Y Shi, MD      

Get Updates

Affiliated With

© 2020 by HS Connect   |  HSConnect.org@gmail.com  |  PO Box 73244 Puyallup, WA 98373  |  253.256.1579